X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NATCO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NATCO PHARMA MERCK LTD/
NATCO PHARMA
 
P/E (TTM) x 33.3 24.1 138.2% View Chart
P/BV x 3.7 18.3 20.4% View Chart
Dividend Yield % 0.8 0.6 121.1%  

Financials

 MERCK LTD   NATCO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NATCO PHARMA
Mar-14
MERCK LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060877 120.9%   
Low Rs623424 147.1%   
Sales per share (Unadj.) Rs632.4223.4 283.1%  
Earnings per share (Unadj.) Rs45.731.1 147.2%  
Cash flow per share (Unadj.) Rs62.340.3 154.7%  
Dividends per share (Unadj.) Rs11.005.00 220.0%  
Dividend yield (eoy) %1.30.8 170.0%  
Book value per share (Unadj.) Rs388.8219.5 177.1%  
Shares outstanding (eoy) m16.6033.07 50.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x1.32.9 45.7%   
Avg P/E ratio x18.420.9 87.9%  
P/CF ratio (eoy) x13.516.1 83.6%  
Price / Book Value ratio x2.23.0 73.1%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96921,504 65.0%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4871,128 131.8%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,4987,389 142.1%  
Other income Rs m242167 145.1%   
Total revenues Rs m10,7417,556 142.1%   
Gross profit Rs m1,1351,793 63.3%  
Depreciation Rs m276304 90.5%   
Interest Rs m0366 0.0%   
Profit before tax Rs m1,1021,290 85.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343309 111.2%   
Profit after tax Rs m7591,027 73.9%  
Gross profit margin %10.824.3 44.6%  
Effective tax rate %31.123.9 130.1%   
Net profit margin %7.213.9 52.0%  
BALANCE SHEET DATA
Current assets Rs m6,4103,681 174.1%   
Current liabilities Rs m8,8283,123 282.7%   
Net working cap to sales %-23.07.6 -304.8%  
Current ratio x0.71.2 61.6%  
Inventory Days Days5889 64.5%  
Debtors Days Days3859 65.4%  
Net fixed assets Rs m1,4067,685 18.3%   
Share capital Rs m166331 50.2%   
"Free" reserves Rs m6,2866,670 94.2%   
Net worth Rs m6,4557,259 88.9%   
Long term debt Rs m0955 0.0%   
Total assets Rs m8,82811,957 73.8%  
Interest coverage xNM4.5-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.6 192.4%   
Return on assets %8.611.7 73.8%  
Return on equity %11.814.2 83.1%  
Return on capital %17.120.7 82.4%  
Exports to sales %8.339.4 21.0%   
Imports to sales %21.05.7 369.2%   
Exports (fob) Rs m8692,908 29.9%   
Imports (cif) Rs m2,209421 524.5%   
Fx inflow Rs m9593,445 27.8%   
Fx outflow Rs m2,612703 371.7%   
Net fx Rs m-1,6532,743 -60.3%   
CASH FLOW
From Operations Rs m1,0701,440 74.3%  
From Investments Rs m-750-1,089 68.8%  
From Financial Activity Rs m-150-353 42.5%  
Net Cashflow Rs m171-1 -11,469.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 1.5 3,523.8%  
Indian inst/Mut Fund % 18.2 7.8 232.1%  
FIIs % 1.0 16.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 26.0 111.9%  
Shareholders   28,591 25,395 112.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   ALEMBIC LTD  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Feb 16, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - DIVIS LABORATORIES COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS